NCT02203266
Completed
Not Applicable
A Randomised, Parallel-group, Multi-centre Trial Using a Novel INCA Tracker Device to Measure and Monitor Compliance and Technique of Seretide Diskus Inhaler in a Community Pharmacy Setting
Beaumont Hospital1 site in 1 country152 target enrollmentFebruary 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- Beaumont Hospital
- Enrollment
- 152
- Locations
- 1
- Primary Endpoint
- Rate of adherence
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to:
- Improved compliance with prescribed inhaler use
- Improved technique of inhaler use
- A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage.
- An improvement in patient quality of life scores
Investigators
Professor Richard Costello
Professor Richard Costello
Beaumont Hospital
Eligibility Criteria
Inclusion Criteria
- •Must be 18 years old or above
- •Capable of understanding and willing to provide voluntary informed consent before any protocol specific procedures are performed
- •Capable of understanding and complying with the requirements of the protocol, and demonstrating a willingness to attend for all required visits.
- •Able and willing to take inhaled medication.
- •Have a valid prescription for use of a Seretide diskus inhaler or already using a Seretide diskus inhaler.
- •Have a history of regular attendance in the pharmacy in which they are recruited which will be demonstrated by the subject having collected three prescriptions for any medication in that pharmacy in the six months preceeding their recruitment to the study.
Exclusion Criteria
- •Patient expressly reports that their physician has indicated that they will not be continuing to receive Seretide over the next 6 months
Outcomes
Primary Outcomes
Rate of adherence
Time Frame: 2 months and 6 months
The rate of adherence is the proportion of correctly taken drugs at the correct time relative to the prescribed interval.
Secondary Outcomes
- Rescue antibiotic and/or steroid medication use(6 months)
- Adherence in the time domain(Two months and six months)
- Rescue inhaled medication use(Six months)
- Quality of life(2 months and 6 months)
- Technique adherence(Two months and six months)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Effect of a Dietary Supplement on Weight Loss and Psychological Wellbeing in Overweight IndividualsOverweightNCT05758363Universidad Católica San Antonio de Murcia60
Completed
Phase 3
Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)Anesthesia, GeneralNCT00475215Merck Sharp & Dohme LLC86
Recruiting
Phase 2
SAMe Trial for Patients With Alcoholic CirrhosisAlcoholic CirrhosisNCT04250259Indiana University196
Completed
Phase 3
Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.Erectile DysfunctionNCT01305083Abdi Ibrahim Ilac San. ve Tic A.S.118
Completed
Phase 3
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck PainAcute PainNCT02700815Boehringer Ingelheim746